Integrative study reveals the prognostic and immunotherapeutic value of CD274 and PDCD1LG2 in pan-cancer

Background: Disorders of CD274 and PDCD1LG2 contribute to immune escape in human cancers, and treatment with anti-programmed death receptor 1 (PD-1) has been widely used in recurrent or metastatic tumors. However, integrated studies considering CD274 and PDCD1LG2 across cancers remain limited. Mater...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xuan, Wang, Yu, Zheng, Jianwei, Wang, Sinan, Liu, Chao, Yao, Xiaofeng, Ren, Yu, Wang, Xudong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582533/
https://www.ncbi.nlm.nih.gov/pubmed/36276934
http://dx.doi.org/10.3389/fgene.2022.990301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582533/
https://www.ncbi.nlm.nih.gov/pubmed/36276934
http://dx.doi.org/10.3389/fgene.2022.990301

Ejemplares similares